REPORT ID 4862

Asia-Pacific Meningococcal Vaccines Market Report 2017

Publish Date
19-Dec-17
Pages
108
Format
Electronic (PDF)

In this report, the Asia-Pacific Meningococcal Vaccines market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split Asia-Pacific into several key Regions, with sales (K Units), revenue (Million USD), market share and growth rate of Meningococcal Vaccines for these regions, from 2012 to 2022 (forecast), including
    China
    Japan
    South Korea
    Taiwan
    India
    Southeast Asia
    Australia

Asia-Pacific Meningococcal Vaccines market competition by top manufacturers/players, with Meningococcal Vaccines sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
    GlaxoSmithKline
    JN-International Medical
    Novartis International
    Sanofi
    Pfizer
    Baxter International
    ...

On the basis of product, this report displays the sales volum, revenue, product price, market share and growth rate of each type, primarily split into
    Menactra
    Menomune

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
    Pneumonia
    Meningitis
    Bacteremia
    Others (Arthritis, Conjunctivitis, Urethritis)

If you have any special requirements, please let us know and we will offer you the report as you want.

 
			   
Table of Contents

Asia-Pacific Meningococcal Vaccines Market Report 2017
1 Meningococcal Vaccines Overview
    1.1 Product Overview and Scope of Meningococcal Vaccines
    1.2 Classification of Meningococcal Vaccines by Product Category
        1.2.1 Asia-Pacific Meningococcal Vaccines Market Size (Sales) Comparison by Types (2012-2022)
        1.2.2 Asia-Pacific Meningococcal Vaccines Market Size (Sales) Market Share by Type (Product Category) in 2016
        1.2.3 Menactra
        1.2.4 Menomune
    1.3 Asia-Pacific Meningococcal Vaccines Market by Application/End Users
        1.3.1 Asia-Pacific Meningococcal Vaccines Sales (Volume) and Market Share Comparison by Applications (2012-2022)
        1.3.2 Pneumonia
        1.3.3 Meningitis
        1.3.4 Bacteremia
        1.3.5 Others (Arthritis, Conjunctivitis, Urethritis)
    1.4 Asia-Pacific Meningococcal Vaccines Market by Region
        1.4.1 Asia-Pacific Meningococcal Vaccines Market Size (Value) Comparison by Region (2012-2022)
        1.4.2 China Status and Prospect (2012-2022)
        1.4.3 Japan Status and Prospect (2012-2022)
        1.4.4 South Korea Status and Prospect (2012-2022)
        1.4.5 Taiwan Status and Prospect (2012-2022)
        1.4.6 India Status and Prospect (2012-2022)
        1.4.7 Southeast Asia Status and Prospect (2012-2022)
        1.4.8 Australia Status and Prospect (2012-2022)
    1.5 Asia-Pacific Market Size (Value and Volume) of Meningococcal Vaccines (2012-2022)
        1.5.1 Asia-Pacific Meningococcal Vaccines Sales and Growth Rate (2012-2022)
        1.5.2 Asia-Pacific Meningococcal Vaccines Revenue and Growth Rate (2012-2022)

2 Asia-Pacific Meningococcal Vaccines Competition by Players/Suppliers, Region, Type and Application
    2.1 Asia-Pacific Meningococcal Vaccines Market Competition by Players/Suppliers
        2.1.1 Asia-Pacific Meningococcal Vaccines Sales Volume and Market Share of Key Players/Suppliers (2012-2017)
        2.1.2 Asia-Pacific Meningococcal Vaccines Revenue and Share by Players/Suppliers (2012-2017)
    2.2 Asia-Pacific Meningococcal Vaccines (Volume and Value) by Type
        2.2.1 Asia-Pacific Meningococcal Vaccines Sales and Market Share by Type (2012-2017)
        2.2.2 Asia-Pacific Meningococcal Vaccines Revenue and Market Share by Type (2012-2017)
    2.3 Asia-Pacific Meningococcal Vaccines (Volume) by Application
    2.4 Asia-Pacific Meningococcal Vaccines (Volume and Value) by Region
        2.4.1 Asia-Pacific Meningococcal Vaccines Sales and Market Share by Region (2012-2017)
        2.4.2 Asia-Pacific Meningococcal Vaccines Revenue and Market Share by Region (2012-2017)

3 China Meningococcal Vaccines (Volume, Value and Sales Price)
    3.1 China Meningococcal Vaccines Sales and Value (2012-2017)
        3.1.1 China Meningococcal Vaccines Sales Volume and Growth Rate (2012-2017)
        3.1.2 China Meningococcal Vaccines Revenue and Growth Rate (2012-2017)
        3.1.3 China Meningococcal Vaccines Sales Price Trend (2012-2017)
    3.2 China Meningococcal Vaccines Sales Volume and Market Share by Type
    3.3 China Meningococcal Vaccines Sales Volume and Market Share by Application

4 Japan Meningococcal Vaccines (Volume, Value and Sales Price)
    4.1 Japan Meningococcal Vaccines Sales and Value (2012-2017)
        4.1.1 Japan Meningococcal Vaccines Sales Volume and Growth Rate (2012-2017)
        4.1.2 Japan Meningococcal Vaccines Revenue and Growth Rate (2012-2017)
        4.1.3 Japan Meningococcal Vaccines Sales Price Trend (2012-2017)
    4.2 Japan Meningococcal Vaccines Sales Volume and Market Share by Type
    4.3 Japan Meningococcal Vaccines Sales Volume and Market Share by Application

5 South Korea Meningococcal Vaccines (Volume, Value and Sales Price)
    5.1 South Korea Meningococcal Vaccines Sales and Value (2012-2017)
        5.1.1 South Korea Meningococcal Vaccines Sales Volume and Growth Rate (2012-2017)
        5.1.2 South Korea Meningococcal Vaccines Revenue and Growth Rate (2012-2017)
        5.1.3 South Korea Meningococcal Vaccines Sales Price Trend (2012-2017)
    5.2 South Korea Meningococcal Vaccines Sales Volume and Market Share by Type
    5.3 South Korea Meningococcal Vaccines Sales Volume and Market Share by Application

6 Taiwan Meningococcal Vaccines (Volume, Value and Sales Price)
    6.1 Taiwan Meningococcal Vaccines Sales and Value (2012-2017)
        6.1.1 Taiwan Meningococcal Vaccines Sales Volume and Growth Rate (2012-2017)
        6.1.2 Taiwan Meningococcal Vaccines Revenue and Growth Rate (2012-2017)
        6.1.3 Taiwan Meningococcal Vaccines Sales Price Trend (2012-2017)
    6.2 Taiwan Meningococcal Vaccines Sales Volume and Market Share by Type
    6.3 Taiwan Meningococcal Vaccines Sales Volume and Market Share by Application

7 India Meningococcal Vaccines (Volume, Value and Sales Price)
    7.1 India Meningococcal Vaccines Sales and Value (2012-2017)
        7.1.1 India Meningococcal Vaccines Sales Volume and Growth Rate (2012-2017)
        7.1.2 India Meningococcal Vaccines Revenue and Growth Rate (2012-2017)
        7.1.3 India Meningococcal Vaccines Sales Price Trend (2012-2017)
    7.2 India Meningococcal Vaccines Sales Volume and Market Share by Type
    7.3 India Meningococcal Vaccines Sales Volume and Market Share by Application

8 Southeast Asia Meningococcal Vaccines (Volume, Value and Sales Price)
    8.1 Southeast Asia Meningococcal Vaccines Sales and Value (2012-2017)
        8.1.1 Southeast Asia Meningococcal Vaccines Sales Volume and Growth Rate (2012-2017)
        8.1.2 Southeast Asia Meningococcal Vaccines Revenue and Growth Rate (2012-2017)
        8.1.3 Southeast Asia Meningococcal Vaccines Sales Price Trend (2012-2017)
    8.2 Southeast Asia Meningococcal Vaccines Sales Volume and Market Share by Type
    8.3 Southeast Asia Meningococcal Vaccines Sales Volume and Market Share by Application

9 Australia Meningococcal Vaccines (Volume, Value and Sales Price)
    9.1 Australia Meningococcal Vaccines Sales and Value (2012-2017)
        9.1.1 Australia Meningococcal Vaccines Sales Volume and Growth Rate (2012-2017)
        9.1.2 Australia Meningococcal Vaccines Revenue and Growth Rate (2012-2017)
        9.1.3 Australia Meningococcal Vaccines Sales Price Trend (2012-2017)
    9.2 Australia Meningococcal Vaccines Sales Volume and Market Share by Type
    9.3 Australia Meningococcal Vaccines Sales Volume and Market Share by Application

10 Asia-Pacific Meningococcal Vaccines Players/Suppliers Profiles and Sales Data
    10.1 GlaxoSmithKline
        10.1.1 Company Basic Information, Manufacturing Base and Competitors
        10.1.2 Meningococcal Vaccines Product Category, Application and Specification
            10.1.2.1 Product A
            10.1.2.2 Product B
        10.1.3 GlaxoSmithKline Meningococcal Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
        10.1.4 Main Business/Business Overview
    10.2 JN-International Medical
        10.2.1 Company Basic Information, Manufacturing Base and Competitors
        10.2.2 Meningococcal Vaccines Product Category, Application and Specification
            10.2.2.1 Product A
            10.2.2.2 Product B
        10.2.3 JN-International Medical Meningococcal Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
        10.2.4 Main Business/Business Overview
    10.3 Novartis International
        10.3.1 Company Basic Information, Manufacturing Base and Competitors
        10.3.2 Meningococcal Vaccines Product Category, Application and Specification
            10.3.2.1 Product A
            10.3.2.2 Product B
        10.3.3 Novartis International Meningococcal Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
        10.3.4 Main Business/Business Overview
    10.4 Sanofi
        10.4.1 Company Basic Information, Manufacturing Base and Competitors
        10.4.2 Meningococcal Vaccines Product Category, Application and Specification
            10.4.2.1 Product A
            10.4.2.2 Product B
        10.4.3 Sanofi Meningococcal Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
        10.4.4 Main Business/Business Overview
    10.5 Pfizer
        10.5.1 Company Basic Information, Manufacturing Base and Competitors
        10.5.2 Meningococcal Vaccines Product Category, Application and Specification
            10.5.2.1 Product A
            10.5.2.2 Product B
        10.5.3 Pfizer Meningococcal Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
        10.5.4 Main Business/Business Overview
    10.6 Baxter International
        10.6.1 Company Basic Information, Manufacturing Base and Competitors
        10.6.2 Meningococcal Vaccines Product Category, Application and Specification
            10.6.2.1 Product A
            10.6.2.2 Product B
        10.6.3 Baxter International Meningococcal Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
        10.6.4 Main Business/Business Overview
    ...

11 Meningococcal Vaccines Manufacturing Cost Analysis
    11.1 Meningococcal Vaccines Key Raw Materials Analysis
        11.1.1 Key Raw Materials
        11.1.2 Price Trend of Key Raw Materials
        11.1.3 Key Suppliers of Raw Materials
        11.1.4 Market Concentration Rate of Raw Materials
    11.2 Proportion of Manufacturing Cost Structure
        11.2.1 Raw Materials
        11.2.2 Labor Cost
        11.2.3 Manufacturing Expenses
    11.3 Manufacturing Process Analysis of Meningococcal Vaccines

12 Industrial Chain, Sourcing Strategy and Downstream Buyers
    12.1 Meningococcal Vaccines Industrial Chain Analysis
    12.2 Upstream Raw Materials Sourcing
    12.3 Raw Materials Sources of Meningococcal Vaccines Major Manufacturers in 2016
    12.4 Downstream Buyers

13 Marketing Strategy Analysis, Distributors/Traders
    13.1 Marketing Channel
        13.1.1 Direct Marketing
        13.1.2 Indirect Marketing
        13.1.3 Marketing Channel Development Trend
    13.2 Market Positioning
        13.2.1 Pricing Strategy
        13.2.2 Brand Strategy
        13.2.3 Target Client
    13.3 Distributors/Traders List

14 Market Effect Factors Analysis
    14.1 Technology Progress/Risk
        14.1.1 Substitutes Threat
        14.1.2 Technology Progress in Related Industry
    14.2 Consumer Needs/Customer Preference Change
    14.3 Economic/Political Environmental Change

15 Asia-Pacific Meningococcal Vaccines Market Forecast (2017-2022)
    15.1 Asia-Pacific Meningococcal Vaccines Sales Volume, Revenue and Price Forecast (2017-2022)
        15.1.1 Asia-Pacific Meningococcal Vaccines Sales Volume and Growth Rate Forecast (2017-2022)
        15.1.2 Asia-Pacific Meningococcal Vaccines Revenue and Growth Rate Forecast (2017-2022)
        15.1.3 Asia-Pacific Meningococcal Vaccines Price and Trend Forecast (2017-2022)
    15.2 Asia-Pacific Meningococcal Vaccines Sales Volume, Revenue and Growth Rate Forecast by Region (2017-2022)
        15.2.1 Asia-Pacific Meningococcal Vaccines Sales Volume and Growth Rate Forecast by Region (2017-2022)
        15.2.2 Asia-Pacific Meningococcal Vaccines Revenue and Growth Rate Forecast by Region (2017-2022)
        15.2.3 China Meningococcal Vaccines Sales, Revenue and Growth Rate Forecast (2017-2022)
        15.2.4 Japan Meningococcal Vaccines Sales, Revenue and Growth Rate Forecast (2017-2022)
        15.2.5 South Korea Meningococcal Vaccines Sales, Revenue and Growth Rate Forecast (2017-2022)
        15.2.6 Taiwan Meningococcal Vaccines Sales, Revenue and Growth Rate Forecast (2017-2022)
        15.2.7 India Meningococcal Vaccines Sales, Revenue and Growth Rate Forecast (2017-2022)
        15.2.8 Southeast Asia Meningococcal Vaccines Sales, Revenue and Growth Rate Forecast (2017-2022)
        15.2.9 Australia Meningococcal Vaccines Sales, Revenue and Growth Rate Forecast (2017-2022)
    15.3 Asia-Pacific Meningococcal Vaccines Sales, Revenue and Price Forecast by Type (2017-2022)
        15.3.1 Asia-Pacific Meningococcal Vaccines Sales Forecast by Type (2017-2022)
        15.3.2 Asia-Pacific Meningococcal Vaccines Revenue Forecast by Type (2017-2022)
        15.3.3 Asia-Pacific Meningococcal Vaccines Price Forecast by Type (2017-2022)
    15.4 Asia-Pacific Meningococcal Vaccines Sales Forecast by Application (2017-2022)

16 Research Findings and Conclusion

17 Appendix
    17.1 Methodology/Research Approach
        17.1.1 Research Programs/Design
        17.1.2 Market Size Estimation
        17.1.3 Market Breakdown and Data Triangulation
    17.2 Data Source
        17.2.1 Secondary Sources
        17.2.2 Primary Sources
    17.3 Disclaimer